HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism

dc.contributor.authorDu, Weinan
dc.contributor.authorZhang, Luchang
dc.contributor.authorBrett-Morris, Adina
dc.contributor.authorAguila, Brittany
dc.contributor.authorKerner, Janos
dc.contributor.authorHoppel, Charles L.
dc.contributor.authorPuchowicz, Michelle
dc.contributor.authorSerra i Cucurull, Dolors
dc.contributor.authorHerrero Rodríguez, Laura
dc.contributor.authorRini, Brian I.
dc.contributor.authorCampbell, Steven
dc.contributor.authorWelford, Scott M.
dc.date.accessioned2018-01-31T13:44:26Z
dc.date.available2018-01-31T13:44:26Z
dc.date.issued2017-11-24
dc.date.updated2018-01-31T13:44:26Z
dc.description.abstractClear cell renal cell carcinoma (ccRCC) is histologically defined by its lipid and glycogen-rich cytoplasmic deposits. Alterations in the VHL tumor suppressor stabilizing the hypoxiainducible factors (HIFs) are the most prevalent molecular features of clear cell tumors. The significance of lipid deposition remains undefined. We describe the mechanism of lipid deposition in ccRCC by identifying the rate-limiting component of mitochondrial fatty acid transport, carnitine palmitoyltransferase 1A (CPT1A), as a direct HIF target gene. CPT1A is repressed by HIF1 and HIF2, reducing fatty acid transport into the mitochondria, and forcing fatty acids to lipid droplets for storage. Droplet formation occurs independent of lipid source, but only when CPT1A is repressed. Functionally, repression of CPT1A is critical for tumor formation, as elevated CPT1A expression limits tumor growth. In human tumors, CPT1A expression and activity are decreased versus normal kidney; and poor patient outcome associates with lower expression of CPT1A in tumors in TCGA. Together, our studies identify HIF control of fatty acid metabolism as essential for ccRCC tumorigenesis.
dc.format.extent12 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec674677
dc.identifier.issn2041-1723
dc.identifier.pmid29176561
dc.identifier.urihttps://hdl.handle.net/2445/119454
dc.language.isoeng
dc.publisherNature Publishing Group
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s41467-017-01965-8
dc.relation.ispartofNature Communications, 2017, vol. 8, num. 1, p. 1769
dc.relation.urihttps://doi.org/10.1038/s41467-017-01965-8
dc.rightscc-by (c) Du, Weinan et al., 2017
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Bioquímica i Fisiologia)
dc.subject.classificationCàncer de ronyó
dc.subject.classificationÀcids grassos
dc.subject.classificationLípids
dc.subject.classificationMetabolisme
dc.subject.classificationMitocondris
dc.subject.otherRenal cancer
dc.subject.otherFatty acids
dc.subject.otherLipids
dc.subject.otherMetabolism
dc.subject.otherMitochondria
dc.titleHIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
674677.pdf
Mida:
2.34 MB
Format:
Adobe Portable Document Format